List view / Grid view

post-transplant lymphoproliferative disorder

 

news

Cancer treatment receives EU drug designations

20 July 2016 | By Niamh Louise Marriott, Digital Content Producer

With the EU orhpan drug designations, Cell Medica can now obtain regulatory and financial incentives for developing and marketing CMD-003 as a cancer...